The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia.

MLA

Godwin, Colin D., et al. “The CD33 Splice Isoform Lacking Exon 2 as Therapeutic Target in Human Acute Myeloid Leukemia.” Leukemia, vol. 34, no. 9, Sept. 2020, pp. 2479–83. EBSCOhost, https://doi.org/10.1038/s41375-020-0755-7.

APA

Godwin, C. D., Laszlo, G. S., Wood, B. L., Correnti, C. E., Bates, O. M., Garling, E. E., Mao, Z. J., Beddoe, M. E., Lunn, M. C., Humbert, O., Kiem, H.-P., & Walter, R. B. (2020). The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia. Leukemia, 34(9), 2479–2483. https://doi.org/10.1038/s41375-020-0755-7

Chicago

Godwin, Colin D, George S Laszlo, Brent L Wood, Colin E Correnti, Olivia M Bates, Eliotte E Garling, Zhengwei J Mao, et al. 2020. “The CD33 Splice Isoform Lacking Exon 2 as Therapeutic Target in Human Acute Myeloid Leukemia.” Leukemia 34 (9): 2479–83. doi:10.1038/s41375-020-0755-7.